Study of RNAi Targeting Epidermal Growth Factor Receptor on Lung Adenocarcinoma A549 Cell Line Growth and Sensitivity to Cisplatin

ZHOU Cui-hong,QI Xie-fei

DOI: https://doi.org/10.3760/cma.j.issn.1673-436x.2009.010.008

2009-01-01

Abstract:Objective Using RNA interference(RNAi)technique,to observe the effect of recombinant plasmid carrying epidermal growth factor receptor(EGFR)homologous gene on the biological characteristics of A549 cell and sensitivity to cisplatin after being transfected to non-small cell lung cancer A549 cell.Methods According to the principle of RNAi,a strip of interfering fragment targeting EGFR gene,h-EGFR was designed and synthesized,then pGensil-1 was used fls vector,the recombinant plasmid pGensil-1-EGFR was constructed and transfected into human lung cancer A549 celIline mediated by Lipofectamine 2000.Then the transfected cells were selected with G418 and the stable transfected monoclone cells were picked out.After being collected and cultured,cells were treated with different concentrations of cisplatin(2.5 mg/L,10 mg/L,40 rag/L)for different time(24 h,48 h,72 h).The antiproliferative effects of dsRNA and cisplatin were assessed by MTT.Cell cycle analysis and the apoptosis rate were carried out via flow cytometry.Results Compared with control group,experiment group grew more slowly,the optical density value was down regulated significantly(P＜0.05).Treated with cisplatin of 40 mg/L,10 mg/L,2.5 mg/L,the inhibition ratio of pGensil-1-EGFR-3 increased by 7.8%,30.70%,34.42%compared with un-transfected control.Cell cycle analysis showed that dsRNA-EGFR induced accumulation of cells in G0-G1 phase by 13.84 0A and decreased in the percentage of cells in S-phase by 19.10%compared with control group.After 24 hours treatment with cisplatin of 40 mg/L,10 mg/L,2.5 mg/L,the apoptosis rates increased compared with that of control group.Conclusions Via stable transfeetion,recombinant plasmid targeting EGFR gene could effectively inhibit cell growth,make more cells block in the G0-G1 phase and could increase the sensitivity of A549 cell to cisplatin.This provides an experimental basis for RNAi technique in gene therapy on non-small cell lung cancer.